Takeda at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Takeda brings 4 presentations to SCOPE 2027 in Orlando. Its sessions cover intentional inclusion in study enrollment, research site finances and the digital transformation of trials. A concrete question it takes up is whether centralized monitoring actions actually worked.

Organization	SCOPE 2027 Attendance
Takeda Tokyo, Japan
takeda.com Large pharma Japanese global pharmaceutical company with medicines in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.	Talk Tue Mar 2 3:05pm–3:30pm Beyond Compliance: How TAK-113 Is Outperforming Expectations through Intentional Inclusion Feasibility & Site Strategy Panel Wed Mar 3 9:00am–9:50am The Business of Clinical Research Sites: Healthy Margins Build Sustainable Research Budgeting & Resources · with Boehringer Ingelheim, Clinical Research Site Collective Talk Wed Mar 3 2:35pm–3:00pm Closing the Loop: Did Our Centralized Monitoring Actions Actually Work? Plenary Quality, monitoring and safety Panel Wed Mar 3 4:12pm–4:42pm KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient Plenary · with Johnson & Johnson, Regeneron, Astellas Pharma +1 more Digital measures and eClinical technologyTrial design and delivery

Organization

SCOPE 2027 Attendance

Takeda

Tokyo, Japan

takeda.com

Large pharma

Japanese global pharmaceutical company with medicines in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience.

Talk

Tue Mar 2
3:05pm–3:30pm

Beyond Compliance: How TAK-113 Is Outperforming Expectations through Intentional Inclusion

Feasibility & Site Strategy

Panel